161 related articles for article (PubMed ID: 29321236)
1. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
[TBL] [Abstract][Full Text] [Related]
2. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M
J Am Coll Cardiol; 2022 Apr; 79(14):1369-1381. PubMed ID: 35393018
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
[TBL] [Abstract][Full Text] [Related]
5. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
6. Pro-atrial natriuretic peptide and prediction of atrial fibrillation and stroke: The Malmö Preventive Project.
Berntsson J; Smith JG; Nilsson PM; Hedblad B; Melander O; Engström G
Eur J Prev Cardiol; 2017 May; 24(8):788-795. PubMed ID: 28195503
[TBL] [Abstract][Full Text] [Related]
7. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
8. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
10. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
Katan M; Moon Y; von Eckardstein A; Spanaus K; DeRosa J; Gutierrez J; DeCarli C; Wright C; Sacco R; Elkind M
Stroke; 2017 Mar; 48(3):604-610. PubMed ID: 28123058
[TBL] [Abstract][Full Text] [Related]
12. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.
Lindberg S; Jensen JS; Pedersen SH; Galatius S; Goetze JP; Mogelvang R
Eur J Prev Cardiol; 2015 Jun; 22(6):693-700. PubMed ID: 24906365
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
Karakas M; Jaensch A; Breitling LP; Brenner H; Koenig W; Rothenbacher D
Clin Chem; 2014 Nov; 60(11):1441-9. PubMed ID: 25139456
[TBL] [Abstract][Full Text] [Related]
14. Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
Hahad O; Wild PS; Prochaska JH; Schulz A; Lackner KJ; Pfeiffer N; Schmidtmann I; Michal M; Beutel M; Daiber A; Münzel T
Clin Res Cardiol; 2021 Jan; 110(1):29-39. PubMed ID: 32306084
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
16. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P
Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937
[TBL] [Abstract][Full Text] [Related]
17. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
18. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
[TBL] [Abstract][Full Text] [Related]
19. Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: a pilot study.
Frontzek K; Fluri F; Siemerkus J; Müller B; Gass A; Christ-Crain M; Katan M
PLoS One; 2014; 9(3):e92421. PubMed ID: 24647802
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Potential of Atrial Natriuretic Peptide on the Development of Postoperative Atrial Fibrillation after Cardiac Surgery.
Hofer F; Hammer A; Steininger M; Kazem N; Koller L; Steinlechner B; Laufer G; Andreas M; Marculescu R; Hengstenberg C; Wojta J; Niessner A; Sulzgruber P
Thromb Haemost; 2021 Nov; 121(11):1523-1529. PubMed ID: 33634445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
